Skip to content
Monday 10 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,862.50
-0.35%
DAX
26,323.88
+0.02%
CAC 40
8,726.03
+0.13%
STOXX 50
6,535.62
+0.18%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Monday 22 August 2022 8:16 am  |  Updated:  Monday 22 August 2022 3:24 pm

Chrysalis portfolio slides 23 per cent as Klarna plunges in value

By: Charlie Conchie

City Editor

Add as a preferred source on Google
Klarna Ireland App Launch Party
Klarna's costs have soared as it ramped up its expansion in the US

Prolific tech investor Chrysalis Investments said the value of its portfolio had plunged 22.8 in the second quarter of the year as its stakes in firms including Klarna and Starling were hit by a global rout in the tech sector.

Bosses said today that valuations in its portfolio had been battered by “historic levels of inflation” and interest rate hikes which have dragged down tech valuations globally.

Klarna, which represented 19 per cent of the investor’s portfolio in March, has been rocked by a 78 per cent fall in value after a funding round in mid-June, while Starling Bank has been written down in line with its peers despite reporting a first profit in the period.

Co-portfolio managers Richard Watts and Nick Williamson said an uptick on markets was expected to lift valuations in its portfolio back in the period ahead, however. 

“Equity markets have rebounded very strongly since the 30 June, and we note the very strong performance of some of the listed peers we benchmark our portfolio assets against,” the pair said in a statement. 

“This has already been reflected in one of our portfolio assets raising primary capital at a premium to its previous funding round and should lead to future NAV progression, if these recent gains are sustained.”

Watts and Williamson said the investor had over £48m cash and £57m of listed assets, which together represent 20.4 per cent of the market capitalisation, and that Chrysalis remained in a “very strong position” heading into the second half the year.

The firm also backed a number of funding rounds for its portfolio in the quarter, including a £10m injection into an £1305m April funding round for Starling Bank, as well as Klarna’s $800m July fundraise with $8.7m. 

Read more

Chrysalis marks down Starling stake again and reduces Klarna holding

Hand inserting a turquoise Starling Bank PCA debit card with Mastercard logo into a brown wallet.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Fintech
  • Investing

Related Topics

  • Klarna

Trending Articles

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Thames Water faces fresh threat to survival after pensions regulation breach

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

  • Hargreaves Lansdown orders staff back to office

  • As it happened: Intel, Arm shares slide; Oil climbs higher

More from Morning Wire

  • Chrysalis marks down Starling stake again and reduces Klarna holding

    Banking
    Hand inserting a turquoise Starling Bank PCA debit card with Mastercard logo into a brown wallet.
  • UK fintech Starling to axe 130 roles in AI-powered simplification drive

    Fintech
    Starling Bank integrates Apple Pay 2022, showcasing digital banking innovation and seamless mobile payment solutions
  • UK investors turn to bonds as equities valuations continue to stretch

    Markets
    Traders analyzing data on screens at London Stock Exchange, showcasing investment trends and market activity
  • Workspace urges investors to block ‘destructive’ Saba proposals

    Property
    Workspace Group said occupancy was down very slightly to 88.1 per cent, compared to 88.4 per cent at the end of last year. 
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Clearlake Capital Announces Partnership with Databricks to Advance AI-Enabled Investing and Portfolio Value Creation

    Business Wire
  • FTSE 100 property firm slams ‘opportunistic, one-sided, inadequate’ takeover offer

    Property
    David Sleath, Chief Executive Officer, delivering a speech at a business conference with a focused expression.
  • IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners.

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook